The first genome sequence assemblies of farm animal species are now accessible through public domain databases, and further sequencing projects are in rapid progress. In addition, large collections of expressed sequences have been obtained, which will aid in constructing annotated transcript maps for many economically important species. Thus, the breeding of farm animals is entering the post-genome era. Functional genomics, defined as applying global experimental approaches to assess gene function, by using the information and reagents provided by structural genomics (i.e. mapping and sequencing), has become the focus of interest. Combining a holistic view of phenotypes at the molecular level with genetic marker data seems a particularly promising approach for improving health and welfare traits in farm animals. These traits are often difficult to define. They suffer from low heritabilities and a corresponding lack of genetic gain in conventional selection and breeding programmes. At the same time, genomic information from micro-organisms and parasites offers the potential for new vaccines and therapeutics. This review describes major functional genomics tools, lists genomic resources available for farm animals and discusses the prospects and challenges of functional genomics in improving the health and welfare of farm animals.
Introduction
Farm animal health and welfare traits are mostly complex and multifactorial. They are difficult to define and/or expensive to measure, and are often characterised by low heritabilities. This has hindered genetic gains through conventional selection and breeding programmes. Prime examples of this broad range of economically important traits are, as follows:
-mastitis susceptibility in cattle (106) -resistance to gastro-intestinal nematode infections in sheep (97) -the incidence of splay leg and anal atresia in pigs (119) -resistance to Marek' s disease in chickens (4) -resistance to infectious salmon anaemia in Atlantic salmon (Salmo salar) (84) .
Moreover, this spectrum includes fertility and body conformation traits that are correlated with health and longevity (52, 71) . Marker-assisted selection could significantly improve health and welfare traits (see papers by Williams et al. and Gibson et al. in this issue), and many genome-wide quantitative trait loci (QTL) mapping experiments have indeed identified chromosome regions that harbour genes with important effects on such traits in various species, e.g. cattle (65) . However, confidence intervals for QTL often extend over many centimorgans with hundreds of genes, and complex interactions such as epistasis must be considered (3) . Identifying functional candidate genes and causative mutations will thus be a challenge, especially when traditional reductionist approaches studying one gene, transcript or protein at a time are employed.
The term 'functional genomics' refers to the development and application of holistic (i.e. genome-wide or systemwide) experimental approaches to assess gene function by using the information and reagents provided by structural genomics (i.e. genome mapping and sequencing). This approach is based on data mining, and characterised by large-scale, high-output experimental methodologies combined with statistical and computational analyses of the results. The fundamental strategy behind functional genomics is to expand the scope of biological investigation from studying single genes, transcripts or proteins to studying all genes, transcripts or proteins simultaneously, in a systematic fashion. Functional genomics thus promises to narrow the gap between sequence and function to yield new insights into the behaviour of biological systems (54) .
As of October 2004, genome sequence assemblies of the honey bee (Apis mellifera), chicken (Gallus gallus) and cow (Bos taurus) were accessible through public domain databases. A Danish-Chinese consortium has recently released a partial pig (Sus scrofa) genome sequence for public use (135) . Further sequencing projects for important farm animal species are expected in the near future. In addition, large complementary deoxyribonucleic acid (cDNA) collections of expressed sequences, known as 'expressed sequence tags' (ESTs), are being developed for economically important species, including farmed fish. These EST collections are used to generate gene indices (114) and annotated transcript maps (115) . They are also being used to construct comparative maps which exploit the extensive genomic resources generated for other species, such as humans, mice (Mus musculus) and zebrafish (Brachydanio rerio) (78) . In fact, ESTs are also yielding both the in silico information and the physical substrates needed for large-scale expression analyses (118) . The structural genomic data from farm animal species are accompanied by genomic data from various micro-and macroparasites relevant to farm animals (21, 22) . Structural genomic information about parasites promises advances in the development of new vaccines and treatments (19, 68) . Thus, the breeding of farm animals, as well as the treatment of their parasites, is entering the postgenome era. In this review, the authors describe the major functional genomics tools, list the genomic resources relevant to farm animals, and discuss the prospects and challenges of using functional genomics to improve the health and welfare of farm animals.
Functional genomics tools

High-throughput marker genotyping
Species-specific genome sequences and large EST collections (see 'Structural and functional genomic resources', below) aid in extensive data mining for genetic markers. Genome sequences provide direct access to large numbers of microsatellite markers and, by database sequence mining or re-sequencing, single nucleotide polymorphisms (SNPs). This marker resource can be used to map and fine map QTL, and identify quantitative trait genes and causative quantitative trait nucleotides. Microsatellites provide an efficient medium-resolution mapping tool for initial QTL mapping, but often lack resolution for fine mapping when investigating breeds with limited effective population size, instead of experimental crosses. Furthermore, microsatellites appear to be much more common in mammals than in birds (95) . The SNPs occur at a frequency of approximately 1/500 base pairs (bp) of nucleotide sequence in pigs, cattle and chickens (30, 32, 134) and represent a vast marker resource. Considering the costs of high-throughput genotyping, it should be noted that successfully applying DNA pooling strategies for QTL mapping in farm animals can significantly reduce the number of individuals that need to be analysed (76) .
High-throughput microsatellite genotyping, performed in multiplex polymerase chain reactions (PCR) with capillary electrophoresis instruments, is cost effective, reliable and straightforward (69) . Various concepts and techniques are available for high-throughput SNP genotyping (124) . All SNP genotyping technologies have two components, as follows:
-a method for discriminating between alternative alleles -a method for reporting the presence of alleles in a given DNA sample.
The general methods for allele discrimination are hybridisation/annealing, primer extension and enzymatic cleavage. However, methods for reporting the presence of alleles in a given sample are much more varied. Most signal detection platforms follow the fate of a label in real time or at the assay end point. Mass spectrometry (MS) is unique in that it can be employed to detect the product of the discrimination assay directly (124 
Deoxyribonucleic acid hybridisation to an oligonucleotide chip
In this approach, PCR-amplified DNA, which contains the polymorphisms of interest, is hybridised to an oligonucleotide microarray with thousands of different oligonucleotides of known sequence. These oligonucleotides are gridded onto a solid substrate, such as a glass microscope slide or silicon wafer. Genotyping in most commercially available devices is achieved by allelespecific hybridisation or allele-specific primer extension. Allele identification results from the emission of signals from specific positions on the chip, which allows the sequence around the polymorphism to be deduced (124) . An example is the oligonucleotide chip technology offered by Affymetrix, Inc., whose GeneChip ® platform involves the production of high-density arrays of oligonucleotide probes using a photolithographic process.
Genomic DNA is digested with a restriction enzyme, ligated to adapters and amplified by PCR. The amplified DNA is then fragmented, labelled and hybridised to the array. Each allele is represented and interrogated by 40 overlapping oligonucleotides and, after washing, allelespecific hybridisation (i.e. fluorescence) intensities are recorded and used for genotype calling. Sample throughput is listed as 96 10-K arrays per person per week, which corresponds to approximately 96,000 genotypes. One disadvantage of chip formats that score a standard set of polymorphisms is inflexibility. However, more flexible systems, which allow researchers to develop their own assays, have also been introduced (124 
Mass spectrometry
Mass spectrometers are mature and robust devices for analysing biomolecules and are perfectly suited for SNP typing. In matrix-assisted laser desorption/ionisation timeof-flight (MALDI-TOF), analyte molecules (e.g. allelespecific DNA fragments) and matrix molecules (typically ultraviolet [UV] or infra-red light-absorbing small molecules) are mixed in solution. They are then cocrystallised on a sample plate, which is subsequently loaded into the vacuum chamber of the mass spectrometer. The DNA molecules are gently desorbed and ionised along with the matrix molecules by UV laser irradiation and the resulting charged ions are accelerated under a constant electric voltage, which causes them to fly towards the ion detector. Charged molecules arrive at the detector at different times, depending on their masses (66) . Although several different strategies for allele discrimination were previously combined with MALDI-TOF mass spectrometric detection, only primer extension methods are currently applied in practice for large-scale SNP genotyping (40) . An example is the MassARRAY TM system marketed by Sequenom, Inc., which was one of the first genotyping assays to be coupled with MS. In this approach, a common primer is hybridised adjacent to the polymorphic site. A cocktail mixture of three deoxynucleotides (dNTPs) and one dideoxynucleotide triphosphate (ddNTP) that corresponds to the polymorphic site is added to initiate the primer extension reaction. This reaction generates allele-specific primer extension products that are generally from one to four bases longer than the original primer. The reactions are performed in 384-well microtitre plates and a small aliquot is transferred to the SpectroCHIP bioarray, which is placed into the MALDI-TOF and the mass and correlating genotype are determined in real time (www.sequenom.de /applications/hme_assay.php). The MALDI-TOF is among the most powerful and reliable SNP genotyping methods and a throughput of more than 30,000 genotypes per day can be achieved, with high quality results (40) . Furthermore, the system is amenable to multiplexing and, in principle, the analysis of up to 300 SNPs in a single spot of an MS sample chip is possible. A 384-spot sample plate could thus identify in excess of 100,000 SNPs (66) . In addition, MALDI-TOF MS can also be used for SNP discovery (70) and microsatellite typing (111) .
Pyrosequencing
Another method based on primer extension on a PCRamplified template is Pyrosequencing TM , marketed by Biotage AB, which is capable of delivering a short nucleotide sequence of approximately 50 bp in real-time. Pyrosequencing is therefore suitable for typing SNPs and scoring haplotypes (24) . This method is based on the detection of pyrophosphate, a byproduct of DNA synthesis, which is converted to adenosine triphosphate (ATP), which then stimulates luciferase activity, causing the emission of a chemiluminescent signal. The reaction includes adenosine 5' phosphosulfate (APS) and ATP sulfurylase, which converts APS into ATP in the presence of pyrophosphate. Also present is luciferin (the substrate of luciferase) and apirase, which continuously degrades unincorporated dNTPs and excess ATP. The dNTPs are added to the reaction one by one, and only complementary dNTP will extend the primer, release pyrophosphate in equimolar quantity and cause the production of ATP, which generates a chemiluminescent signal (24, 124) .
Transcriptome analysis
Most physiological processes are accompanied by complex changes in the transcriptome and/or the proteome. A combined holistic analysis of gene expression in cells or tissues at the transcript and protein level is therefore desirable (39) . For reasons detailed in 'Proteome analyses', below, the proteome is at present not amenable to a simultaneous comprehensive analysis, even when 'state of the art' analytical systems are used. The transcriptome, in contrast, may be analysed in a simultaneous and comprehensive manner by various high-throughput methods. These methods include, as follows:
-serial analysis of gene expression (SAGE) -massively parallel signature sequencing (MPSS) -microarray-based transcript analyses (13, 58, 128) .
Such methods can be applied in any species with sufficient EST data and/or genome information for transcript annotation. Microarray-based technology relies on hybridisation signal detection, whereas SAGE and MPSS are based on DNA sequencing and counting 'tags'. The MPSS method generates millions of short sequence tags for counting messenger ribonucleic acid (mRNA) frequencies and provides an unprecedented depth of analysis. A single MPSS experiment can provide a ten-fold coverage of the transcripts expressed in a mammalian cell. This method is, therefore, particularly well suited for identifying rare transcripts and able to generate comprehensive genomewide expression profiles (13) . However, the MPSS approach is complex and difficult to apply in a standard laboratory. Further reading on MPSS is provided in Brenner et al. and Reinartz et al. (13, 101) .
Serial analysis of gene expression
The SAGE technology is based on the principle that a 10-bp cDNA fragment, the tag, contains sufficient information to unambiguously identify a transcript, provided that the tag has been isolated from a defined position within the transcript. The original SAGE protocol is based on the construction of SAGE libraries which contain concatenates of up to 50 short sequence tags, each representing a single mRNA. Initially, double-stranded cDNA is synthesised with a biotinylated oligo(dT) primer and bound to streptavidine-coated beads. The cDNA is cleaved with a restriction endonuclease, the anchoring enzyme, revealing specific fragments of the 3' ends of every single cDNA. Next, specific linker sequences, which contain a recognition site of a Type IIS restriction endonuclease, the tagging enzyme, are ligated to these fragments. Cleavage with this enzyme results in unique sequence tags of 10 bp or 11 bp, plus the 4-bp recognition site of the anchoring enzyme, of every cDNA species. The tags are concatenated and ligated into a cloning vector to create a SAGE library. Each sequencing reaction of one of these cloned concatenates determines the tags of up to 50 mRNA species, accelerating the speed of EST sequencing up to fifty-fold (128) . Sequencing appropriate numbers of clones from SAGE libraries yields hundreds of thousands of tags, and tag identification and counting have identified gene expression profiles of many different cell types and tissues (74) . More recently, SAGE protocols were modified (i.e. Long SAGE, Robust-Long SAGE) to increase tag length to 21 bp (37, 107) . In contrast to conventional SAGE, which allows tag assignments to EST collections, Long SAGE allows unique tag assignments to much more complex genomic sequences. Long SAGE can therefore be used to identify novel genes and exons, and thus aid in genome annotation. Further modifications of the Long SAGE protocol (i.e. 5' and 3' Long SAGE) provide 20 bp tag pairs from the 5'-and 3'-ends of a transcript, which can be used to determine transcription unit boundaries (48, 133) . Various SAGE protocols for very low amounts of initial RNA material have also been designed (130) .
Within-class variability, i.e. variability due to intrinsic biological differences among sampled individuals of the same class, not simply variability due to technical sampling error, is an important challenge for transcript counting methods. Within-class variability must be considered in appropriate statistical models to identify reliable lists of candidate transcripts that show differential expression (129) . Assigning experimentally obtained data to a known transcript is a crucial step in SAGE and MPSS. However, tag-to-transcript assignment is not a straightforward process, since alternative tags for a given transcript can also be obtained experimentally. Therefore, SNP-associated alternative tags must be taken into account (112) . In contrast to microarrays, the SAGE output format is digital and therefore suitable for direct comparisons with data generated by other laboratories. Thus, SAGE should provide a broadly applicable method for the quantitative cataloguing and comparison of expressed genes in a variety of developmental and disease states. The main restriction of the SAGE method is the complexity of the technique and the prerequisite that a reasonable number of ESTs or genes must be known to assign the tags.
Deoxyribonucleic acid microarrays
The basic concept behind all microarrays is the precise positioning and immobilisation of a defined amount of gene-specific DNA fragments (probes) at high density on a solid support. These sequences are then queried by hybridisation with labelled copies of nucleic acids from biological samples (targets). The underlying theory is that the greater the expression of a gene, the greater the amount of labelled target and, hence, the greater the output signal. In principle, this approach is the reversion of a classical Northern blot, with the advantage that, in a single experiment, the expression level of as many genes as are arrayed on the solid support can be determined (58, 110) . Microarrays vary, according to, principally: a) the solid support used (e.g. filters or glass) b) the surface modifications with various substrates c) the type of DNA fragments on the array (e.g. cDNA or oligonucleotides) d) whether the gene fragments are presynthesised and deposited or synthesised in situ e) the machinery used to place the fragments on the array (e.g. ink jet printing or spotting).
Combinations of these variables are used to generate three main types of microarray:
-filter arrays -spotted glass slide arrays -oligonucleotide arrays synthesised in situ.
Filter arrays and spotted arrays can be produced in academic facilities or purchased from commercial sources but high-density oligonucleotide arrays which are synthesised in situ can only be obtained from commercial sources (1, 58 ). An example is the Affymetrix GeneChip ® technology, which uses photolithography and combinatorial chemistry to synthesise probes on quartz wafers.
Ideally, an array for expression profiling consists of sequence validated probes, in which each sequence is unique, shows minimal cross-hybridisation to related sequences and provides, collectively, a comprehensive representation of the expressed fraction of the genome, including splice variants. In gene expression microarrays, either synthetic oligonucleotides or cDNA fragments are used as probes. The principal probe sources for cDNA microarrays are cDNA/EST libraries and known open reading frames in genomic clones such as bacterial artificial chromosome (BAC) libraries. Various clone sets are distributed by and available through licensed vendors, such as the German Resource Centre for Genome Research Deutsches Ressourcenzentrum für Genomforschung: RZPD (www.rzpd.de/). The DNA is typically prepared for arraying by high-throughput PCR. Quality control is crucial for ensuring probe identity and correct assignment (58) . Longer oligonucleotide probes (60 mers to 80 mers) were reported to provide significantly better detection sensitivity than shorter probes (25 mers to 30 mers). However, longer oligonucleotides and cDNA probes are prone to cross-hybridisations. Oligonucleotide hybridisation is highly sequence-dependent and probes binding to different regions of a gene yield different signal intensities. Multiple oligonucleotides have been used in array designs to overcome this problem. Thus, bioinformatics-based oligonucleotide probe design is complex and requires optimisation of probe length and number of probes per gene (15) . Microarray probe specificity in various species, including the chicken and cow, can be evaluated with ProbeLynx (www. pathogenomics.ca/probelynx).
Filter arrays require tiny amounts of RNA for radioactive target labelling, use widely available phosphorimager instrumentation to read and are relatively inexpensive to produce and use. The radioactive detection method requires parallel hybridisations to duplicate filters in order to compare gene expression between samples. Expression analyses using glass slide microarrays are performed by fluorescent labelled target samples. An expression analysis can be performed by competitive hybridisation of two samples, each labelled with a specific fluorescent dye, such as Cy3 or Cy5 (two-colour arrays), or by hybridisation of a single sample (a one-colour array). Experiments with twocolour arrays may be conducted as individual paired comparisons or by comparing each sample against all others. With increasing numbers of samples, the latter approach becomes impractical, both in terms of the number of arrays and the amount of RNA required (1, 58) . Direct sample labelling is inefficient and causes a reduction in sensitivity, in addition to potential dye bias. Indirect labelling protocols that incorporate the dye after reverse transcription have been developed. However, dye bias may still pose a problem in microarray reference designs (25) . Various amplification and high sensitivity techniques have been designed to reduce the substantial amounts of RNA (e.g. 20 µg to 70 µg) that are currently needed in the direct and indirect labelling procedures (79) .
The use of different array platforms, experimental designs, sample preparation protocols and methods of data analysis prevents a direct and reliable comparison of microarray data available in the literature. The Microarray Gene Expression Data Society, an international organisation of microarray users and developers, has proposed common guidelines for designing and reporting microarray experiments (minimum information about a microarray experiment or MIAME) as a first step towards standardised microarray-based gene expression data (12) . The two main types of platforms, radioactive labelling and hybridisation to a cDNA filter array versus fluorescent dye labelling (onecolour array) and hybridisation to an oligonucleotide array, were recently directly compared. This study revealed only moderate overlap in the results of the two array systems. Only 64% of the genes represented on both platforms matched in 'present' or 'absent' calls (81) . Another recent investigation compared six commercially available, highdensity microarray platform types, ranging from a twocolour spotted cDNA array to short in situ synthesised oligonucleotide chips, for variability, sensitivity and correlation. Using significance analysis of microarrays (SAM), there were significant differences among platform types in their ability to detect differential expression between two very different cell types. Oligonucleotide platforms performed better than cDNA arrays, irrespective of whether a one-colour or two-colour approach was used, and there was a remarkable degree of overlap among the three oligonucleotide systems (141) .
Commercial microarray design usually relies on large amounts of sequence information derived from GenBank or other resources. Therefore, these platforms are restricted to organisms with a reasonable amount of sequence data. A powerful approach to detect differentially expressed genes in species with less or even no sequence information is based on microarrayed suppression subtractive hybridisation (SSH) cDNA libraries (139) . The SSH method is founded on a suppression PCR effect and combines normalisation and subtraction in a single procedure. The normalisation step equalises the abundance of cDNA fragments within the target sample population, while the subtraction step reduces the number of sequences that are common to the populations being compared. This dramatically increases the probability of obtaining low-abundance differentially expressed cDNA (100). Owing to enrichment of the transcripts of interest, it is often sufficient to analyse only a few thousand cDNAs of a library (Fig. 1) . The spotted cDNAs are only sequenced after the detection of differential expression, and can be identified and assigned to genes by comparison with the sequence data in public databases (5, 6).
The major prerequisite for a high quality microarray experiment is an appropriate experimental design which is -assign genes to metabolic or other cellular pathways (pathway databases).
Selected database links are presented in Table I . Additional important resources (gene indices, metabolic pathways) are available at www.tigr.org/tdb/tgi/.
Bioinformatics and statistical modelling in transcriptome analysis
Interpreting the output of large-scale microarray experiments requires statistical tools. Each cDNA or oligonucleotide tag (probe) on the array represents a 'variable' and each array represents an 'observation', where the number of arrays is much smaller (usually between 5 and 100) than the number of probes (thousands or tens of thousands). Data analyses include two major steps. Initially, systematic and random variations in microarray experiments must be removed so that the data may be reliably interpreted with statistical methods. This step is denoted as data normalisation and calibration. The second The most popular software tool for statistical analysis of microarray data is 'R', which includes many up-to-date packages implementing well-known biostatistical methods. These packages are free and publicly available from the website of the Bioconductor project (www.bioconductor.org) or from the 'R' homepage (www.R-project.org).
Data normalisation and calibration
The normalisation of high-density oligonucleotide arrays (e.g. Affymetrix) is a specific issue, which has been reviewed in Bolstad et al. (9) . A popular and recognised approach for cDNA microarray data normalisation and calibration is the robust, locally weighted regression normalisation method (140) , which aims to perform location and scale normalisation within each array as well as between different arrays. This method adjusts for differences such as those between print-tip-groups and spatial effects in each array, imbalances between red and green intensities and differences between arrays. It is implemented in the 'R' package 'marray'.
Another method designed for cDNA arrays as well as for high-density oligonucleotide arrays is 'variance stabilisation' (60) . It transforms the data so that the variance of the intensities for each probe across the arrays is independent of its mean, which makes the detection of differential expression more reliable. The method is implemented in the 'R' package 'vsn'. In the rest of this section, the authors assume that the data have been normalised.
Detecting differential expression
The identification of transcripts that are differentially expressed in two distinct groups (e.g. 'disease' and 'no disease') is of major interest. 
Gene expression databases
Gene expression omnibus (GEO)
The GEO is a high-throughput gene expression/molecular abundance data repository, www.ncbi.nlm.nih.gov/geo/ as well as a curated, online resource for gene expression data browsing, query and retrieval Serial analysis of gene expression SAGE tag to gene mapping www.ncbi.nlm.nih.gov/SAGE/ (SAGE) map
Pathway resources
Pathway resource list (PRL)
The PRL is a new database that contains information on 156 internet pathway resources. www.cbio.mskcc.org/prl/ Most of these resources are databases themselves, containing such things as index.php protein-protein interactions or metabolic reactions. In its present form, PRL only provides links to these resources. In the future, PRL will provide additional information such as the amount of data and the organism coverage in each pathway resource 
Multivariate statistical analysis
Apart from differential expression, other interesting questions can be addressed using multivariate statistical methods (117) . These methods are difficult to apply but it is possible to use cluster analyses to look for groups of similarly expressed transcripts that are as homogeneous as possible but as different as possible from the other groups. There are numerous clustering approaches, such as:
-partitioning around medoids -k-means -hierarchical clustering.
Most of these methods are implemented in the 'R' package, 'cluster'. The resulting clusters can often be represented graphically, for instance, using a dimension reduction method. However, clustering methods always form a partition into clusters, even if the data do not have any underlying cluster structure. Thus, clustering methods should be used as data mining tools that may, for instance, support empirical assumptions but should not be interpreted as 'statistical evidence'.
Another topic of interest is classification, where gene expression data are used to assign a sample to one of two (or several) previously identified 'disease' and 'no disease' groups. Classification methods allow the determination of diagnostic rules based on the gene expression data, so that an analysed target sample can be assigned to one of the groups when it is normalised by the same method employed for the other arrays. A comparison study of effective classical classification methods can be found in Dudoit et al. (28) . However, more recent methods, such as 'prediction analysis for microarrays' (120), which is implemented in the 'R' package 'pamr' or 'partial least squares' (11), seem to perform better because they are especially appropriate for high-dimensional data.
Dimension reduction is a family of statistical methods for high-dimensional data. The most widely used dimension reduction method is principal component analysis (PCA). It may be used to visualise microarray data experiments graphically in two or three dimensions. This approach identifies the major sources of variation in the data. The PCA is implemented in 'R' in the function 'prcomp'.
Another important topic is the search for interaction structures between genes. Although data collected at the transcription level miss much potentially useful information, a few data mining approaches deal with the reconstruction of genetic networks using microarray data through graphical models. A recent overview of this topic is presented in Friedman (34) . The 'R' package 'GeneTS' (109) uses a recent statistical method based on Gaussian graphical models to detect interaction structures in the form of statistically significant partial correlations between genes, then produces genetic networks.
Proteome analyses
The transcriptome is a representation or 'snapshot' of the complete set of RNA transcripts of tissues or cells, formed by the dynamic equilibrium between DNA transcription and mRNA degradation. The proteome is the complete set of proteins in a given tissue, cell or biological fluid at a given point in time. It is the result of three major posttranscriptional processes: A major challenge is the complexity of the protein mixtures that must be analysed. In humans, for example, with approximately 30,000 genes, 1.8 million different proteins and protein isoforms are expected (62) . In addition, proteins show an extraordinary variation in concentration, which complicates the detection of low-abundance proteins. The abundance of albumin in blood plasma, for example, differs by more than 10 orders of magnitude from the concentration of low-abundance proteins, such as interleukins (2) . For this reason, proteomes are usually divided into several fractions using pre-fractionation procedures, such as subcellular fractionation and chromatographic and/or electrophoretic separation (132) . Each fraction is then investigated separately and the resulting data are recombined to obtain a more global view of the proteome under study.
Two-dimensional polyacrylamide gel electrophoresis
The most frequently applied method to separate the proteins of a proteome or a proteome fraction is twodimensional polyacrylamide gel electrophoresis (2D-PAGE), initially described by O'Farrell and Klose in 1975 (67, 88) . The procedure consists of two electrophoresis steps with different separation criteria. In the first dimension, proteins are separated according to their isoelectric point. In the second dimension, they are separated according to their molecular weight. Following protein separation, gel-staining techniques (92) generate a spot pattern (Fig. 2) . Ideally, each spot on a 2D gel represents a different protein or a distinct modification state of a single protein. Quantitative and qualitative differences in the protein patterns of samples thus result in quantitative or qualitative alterations in the spot patterns. The 2D-PAGE method is powerful enough to separate and resolve thousands of proteins on a single gel (27) . Typically, several gels are matched and compared using 2D-gel analysis software packages. Differing spots are then excised and identified by protein identification techniques (36), such as MS (Fig. 3) . Although 2D-PAGE was developed almost thirty years ago, it remains a 'state-of-the-art' technique and is amenable to further development. An important enhancement of this technology is the difference gel electrophoresis (DIGE) technique (122, 127) , made available by GE Healthcare. In principle, DIGE consists of: a) derivatising two different samples with two different fluorophores b) combining the two samples c) running the two samples on a single 2D gel (Fig. 4) .
As the label does not affect the migration properties of proteins in the gel, the proteins of both samples are comigrating. Protein detection is performed on a dual laserscanning device with different excitation/emission filters. The images are then matched by a computer-assisted overlay technique, normalising and quantifying the signals. Differences in protein expression are identified by evaluating a pseudo-coloured image and data spreadsheet. To increase the accuracy of the results, internal standardisation can be achieved by labelling the standard with a third fluorophore. 12 C atoms). The protein mixture of sample B is then derivatised in a similar manner with the isotopically heavy reagent (e.g. reagent with 13 C atoms). Following derivatisation, the two samples are combined and enzymatically digested to generate peptide fragments. Finally, the labelled peptides are analysed by LC-MS (Fig. 5) . As the isotope pattern (e.g. 12 C versus 13 C) does not affect their chromatographic characteristics, the differently labelled peptides co-elute and reach the mass spectrometer at the same time. Relative quantification is performed by a comparison of the intensities of corresponding MS-signals of the light and heavy versions of the labelled peptides. Observed peak ratios for isotopic analogues are highly accurate, because there are no chemical differences between the species, and they are analysed in the same experiment. More recently, numerous variations of this approach have been developed (41) . These include isotope-coded affinity tag (ICAT) and cleavable ICAT that employ modified biotin ( 2 H versus 1 H or 13 C versus 12 C), and stable isotope labelling by amino acids in cell culture, which uses labelled amino acids in cell culture media (41, 44, 89) . A large number of studies based on stable isotope labelling have demonstrated the feasibility and efficiency of MS-based proteomics. 
Chip-based methods
As in transcriptomics, chip-based tools have the potential to revolutionise the field of proteomics. An antibodymicroarray consists of a set of antibodies spotted robotically on appropriate solid supports (42) . To measure protein levels, the labelled sample (e.g. with a fluorescent label) is incubated on the surface of the microarray. Then the proteins bound to the antibody probes are quantified using fluorescence array-scanning systems (Fig. 6 ). The potential of this technique has been demonstrated with antibody-arrays targeting very low-abundancy proteins, such as cytokines, which are hardly detectable with standard proteomics techniques (59) . A major challenge is the production of the thousands of antibodies that are needed to perform holistic proteome-wide analyses. The antibodies for array-based experiments must be highly specific and sensitive, even when similar proteins are present in a high concentration. For this reason, projects such as the antibody initiatives of the Human Proteome Organisation have recently begun systematically to generate high-quality antibodies against every human protein (83). Experience gathered with these antibody initiatives will help to establish highly effective array-based protein detection techniques for other species, including farm animals.
Bioinformatics in proteome analyses
A variety of specialised bioinformatics tools are integral parts of the overall workflow in proteome analyses. The frequently employed 2D-PAGE strategy requires software tools for spot detection and quantification on large gel sets. Software packages are also available to match and compare corresponding spots on different gels (27) . However, these tools are not fully automated and results often have to be corrected manually by spot editing and matching. State-ofthe-art LC-MS setups are able to generate up to five spectra per second, leading to thousands of spectra in a single experiment. Protein identification is based on comparisons between experimental MS spectra and in silico-generated MS spectra of known proteins. Several appropriate search algorithms (31) have been developed for this purpose. The huge number of database searches that must be performed may nevertheless constitute a problem and the most sophisticated computing facilities are necessary to overcome this. Thus, computers such as the Proteome Analysis Under Linux Architecture cluster at the Medical Proteome Center in Bochum, Germany, with its ability to search a single spectrum against a protein database with one million entries in 150 milliseconds, are a prerequisite for high-throughput analyses. Managing the large data sets generated in proteome projects is much more difficult than managing those in transcriptome projects. In a typical proteome project, samples are split and processed with completely different approaches to reduce their complexity, and then investigated in individual experiments. All the diverse results must be stored in a manner that allows statistical evaluations and data mining. Finally, the data sets must be reassembled to provide an overview of whole proteomes (33) . Commercial suppliers are now providing integrated software platforms, based on relational databases, that should finally be able to perform the following:
-track samples in the proteomics workflow -control equipment, such as liquid-handling robots and mass spectrometers, in a sample-dependent way -collect, process and store obtained data in central databases.
Strategies for defining gene functions in vivo Transgenesis
Depending on the traits of interest, the mouse is not always an appropriate model to clarify gene function in livestock. However, the functional analysis of genes in farm animals in vivo is a major challenge, since target gene validation through traditional methods, such as transgenesis by DNA micro-injection into zygotes, is costly and cumbersome (137) . Recent progress in farm animal transgenic technology provides a more efficient basis for gene function studies. Somatic cell nuclear transfer (SCNT) has been established for several species and, in combination with random or targeted genetic alteration of nuclear donor cells, enables functional studies (23) . Efficient generation of transgenic livestock using lentiviral vectors (56, 57) is another important step towards studying gene function in these species. Lentiviral vectors can be used for overexpression and also for gene knock-down studies, using small interfering RNAs (121 Long dsRNA and miRNA precursors are processed to siRNA and miRNA duplexes by the RNase-III-like enzyme Dicer. The short dsRNAs are subsequently unwound and assembled into effector complexes: RNA-induced silencing complex (RISC) and miRNA containing ribonucleoprotein particles (miRNPs). The RISC mediates mRNA-target degradation while miRNPs guide translational repression of target mRNAs (10, 82) .
Combined with appropriate constructs and transgenic technology, RNAi has the potential to create animals with inducible, tissue-specific silencing of almost any gene. However, RNAi can also be applied directly, without transgenic approaches, if a suitable system for delivery is available. Applying RNAi to C. elegans is relatively easy and can be accomplished by soaking the worms in appropriate dsRNA solutions (68) . Numerous transfection reagents are commercially available for work with cell lines, but these do not work in vivo. Thus, the main obstacle to achieving in vivo gene knock down by RNAi technologies in farm animals is delivery. Ova and pre-implantation embryos are therefore particularly amenable to RNAi through microinjection or electroporation (45, 93) . However, post-natal tissues have also been targeted by intravenous injection of siRNA in physiological solution (e.g. saline). This approach has been used to deliver siRNAs to highly vascularised mouse tissues, such as the liver and muscle. Knock down of genes targeted in this manner is transient, but may last longer than a week with a reduction in gene expression of 30% to 60%. In vivo gene knock down has also been reported after local, direct administration of siRNAs to sequestered anatomical sites, demonstrating the potential for delivery to organs such as the eyes, lungs and central nervous system. More recently, chemically modified siRNA was employed to induce massive knock down of apolipoprotein B mRNA in the liver and jejunum, which caused significantly decreased plasma levels of apolipoprotein B and a reduction in total cholesterol in mice (116) . This study further demonstrates the power of RNAi as a functional genomics tool for target validation and the study of gene function in vivo. However, care must be taken in siRNA selection and experimental design, including appropriate controls, to ensure potency and specificity in gene knock-down experiments (43) . There are several publications which give practical advice on the experimental application of RNAi in birds and mammals (38, 99, 126) . Moreover, resources for other species are emerging.
Structural and functional genomic resources
Structural genomic resources include the following:
-genetic maps (14, 16, 18, 61, 85, 86, 105, 131) -physical maps (14, 16, 18, 74, 107, 137) Rev. sci. tech. Off. int. Epiz., 24 (1)
-EST collections (14, 16, 18, 20, 102, 103, 105, 125) -SNP collections (14, 49, 125) -large-insert (e.g. BAC) libraries (16, 18, 73, 96, 105) .
For some of these species, the first draft genome sequence assemblies (see 'Introduction', above) are available. Gene indices have also been constructed or are under construction for various species (14, 102, 105, 113, 114, 115) . Comparative maps were developed concurrently with genetic maps and are continuously being refined to link farm animal genome information with the more advanced structural and functional genomic data of other species, such as humans and mice (14, 16, 18, 29, 64, 73, 78, 105) . Recently developed comparative mapping tools (47, 64, 78) 
Microparasite and macroparasite resources
Various parasite genome projects, which aim to collect complete genome sequences and/or EST resources, have been initiated, completed or are about to be completed in the near future. Microparasite projects include a wide range of viruses, protozoa and bacteria. Examples are members of the genus Parapoxvirus (22) , various species of Trypanosoma (21) and strains of Listeria monocytogenes (26 
Examples of functional genomics in farm animal health and welfare
Expression profiling is perhaps the most promising application of functional genomics in farm animal health and welfare. The expression of thousands of genes in a given tissue or cell type is measured simultaneously in two or more biological conditions, such as 'infected' and 'noninfected', and compared to identify differentially expressed transcripts. In a 'proof of principle' experiment in chickens, a limited microarray with only 1,200 genes was able to reproducibly detect gene expression differences in peripheral blood lymphocytes of two strains of Marek' s disease, one susceptible, the other resistant, that were compared before and after infection. These microarray data were found to be consistent with previous data in the literature concerning gene induction and immune response. Moreover, one of the genes with differential expression was known to confer resistance to Marek' s disease, while another gene provided a prime positional QTL candidate (77) . Another experiment used the SAGE approach for profiling gene expression in peripheral blood mononuclear cells of a trypanotolerant N'Dama cow, before and after experimental infection with Trypanosoma congolense. The identification of more than 180 differentially expressed genes and ESTs involved in trypanotolerance will allow the establishment of specific microarray sets for further metabolic and pharmacological studies and the design of marker sets for marker-assisted introgression programmes (8) . In livestock species such as cattle, monozygotic twins provide a valuable resource for this type of experiment, especially when studying fertility problems (137) .
Other examples of QTL projects that will benefit from a molecular phenotype are mastitis resistance (106) and studies aimed at identifying the polled gene in cattle (35) .
As with any functional genomics analysis, temporal and spatial target tissue or cell population definition is vital for success. Laser capture microdissection can obtain relevant cell populations precisely (7) . The recently developed 'genetical genomics' approach to QTL mapping combines classical QTL mapping with molecular phenotypes defined by expression profiles. This approach promises new insights into a wide spectrum of traits (108) . However, this type of study requires a highly standardised experimental setting, since environmentally induced variation in gene expression can be considerable (98) . Such standardisation might be difficult to achieve in some farm animal species.
Another interesting application of gene expression profiling is in assisted reproduction technologies. Embryo production by in vitro fertilisation (IVF) procedures and, even more significantly, by SCNT, is often associated with complex health and welfare problems, collectively known as 'large offspring syndrome' (LOS) (53) . The occurrence and severity of LOS phenotypes depend on the IVF and SCNT protocols and media used and are, at present, rather unpredictable. This has hindered the more widespread application of embryo technologies in animal breeding and production. Microarray analysis has recently been employed to characterise gene expression profiles in IVF and SCNT embryos, and has identified several genes implicated in abnormal phenotypes (94) . Normalising the expression pattern of these genes by appropriate embryo protocols could be a way of improving the health of IVF and SCNT offspring. A more global approach in this field aims to establish a 'gold standard' of normal gene expression in embryos by large-scale microarray analyses. An 'embryo chip' with all the relevant genes could then be used to design and test optimised in vitro protocols and media at the pre-implantation embryo stage, to allow optimal development to term (87) .
Expression profiling in host cells or tissues and parasites is also an extremely valuable tool for the detailed characterisation of host-parasite interactions, as well as for identifying new drug targets or developing new vaccines (68) . A 'genomic filtering' approach is particularly promising in the search for novel antiparasitics. For infectious disease applications, comparative genomics filters allow the selection of pathogen-specific gene products, whereas functional genomics filters, such as RNAi, allow the selection and targeting of gene products that are essential for parasite survival (80) .
Conclusions and prospects
Recent technological advances in 'omics' technologies and their corresponding bioinformatic tools will greatly aid a systematic analysis of molecular changes during physiological and pathological processes. This will provide insights into the biological mechanisms underlying animal health and allow better definition of traits with previously low heritability. Applying the 'genetic genomics' approach to farm animals is a major challenge, principally because maintaining sufficient numbers of large animals under standardised environmental conditions presents problems associated with management, housing and economics. Identifying QTL-affecting molecular profiles through these 'omics' technologies may prove valuable when using marker-assisted selection to improve fertility, health and longevity in farm animals. In turn, molecular profiles of relevant tissues may also be useful to predict the consequences of selection before the animals reach an age at which classical phenotypic traits can be recorded. This represents a first step towards a systems biology approach to complex organisms. Such an approach would aim to model dynamic gene-protein-metabolite signalling networks and enable researchers to predict the outcome of a given perturbation of the system under investigation. Similar approaches are currently being developed and tested in simple model organisms, but may also be applicable to laboratory and farm animals. Thus, functional genomics is expected to have a major positive impact on sustainable livestock production. 
Résumé
Les premiers assemblages de séquences du génome des espèces d'élevage sont désormais accessibles grâce à des banques de données du domaine public ; de plus, d'autres projets de séquençage progressent rapidement. En outre, un grand nombre de séquences exprimées a été obtenu, ce qui contribuera à la construction de cartes de transcrits (gènes annotés) pour de nombreuses espèces qui ont une importance économique. Ainsi, la reproduction des animaux d'élevage entre dans l'ère post-génomique. La génomique fonctionnelle, définie comme étant l'application des méthodes expérimentales globales visant à évaluer la fonction des gènes, en utilisant les données et les réactifs mis à disposition par la génomique structurelle (c'est-à-dire, cartographie et séquençage), capte désormais toute l'attention. La conjugaison d'une vue holistique des phénotypes au niveau moléculaire et des données sur les marqueurs génétiques semble être une approche particulièrement prometteuse pour l'amélioration des caractères liés à la santé et au bien-être chez les animaux d'élevage. Ces caractères sont souvent difficiles à définir. Comme ils ont une héritabilité faible, ils ne sont pas associés à une amélioration génétique dans les programmes de reproduction et de sélection traditionnels. Parallèlement, les informations génomiques obtenues de micro-organismes et de parasites ouvrent des perspectives en matière de nouveaux vaccins et de traitements. Le présent article décrit les principaux outils de la génomique fonctionnelle, énumère les ressources génomiques disponibles pour les animaux d'élevage et examine les perspectives et les problèmes de la génomique fonctionnelle au service de l'amélioration de la santé et du bien-être des animaux d'élevage. 
Mots-clés
Resumen
Ya es posible acceder a los primeros repertorios de secuencias genómicas de especies ganaderas, que figuran en bases de datos de dominio público, y hay otros varios proyectos de secuenciación que avanzan con rapidez. Se han obtenido además amplios conjuntos de secuencias expresadas, que resultarán de ayuda para elaborar mapas de transcripción anotados de numerosas especies de importancia económica. La cría y selección de animales domésticos está entrando pues en la era postgenómica. La genómica funcional, definida como la aplicación de métodos experimentales holísticos para evaluar la función génica a partir de datos y reactivos procedentes de la genómica estructural (esto es, la cartografía y la secuenciación), se está convirtiendo en el área de interés primordial. La combinación de marcadores genéticos y de una visión holística de los fenotipos en su dimensión molecular parece un planteamiento especialmente prometedor para mejorar las características ligadas a la salud y al bienestar del ganado. En general resulta difícil determinar cuáles son estas características, pues su nivel de heredabilidad es bajo y por consiguiente no deparan grandes ventajas genéticas con programas convencionales de cría y selección. Al mismo tiempo, la información sobre el genoma de microorganismos y parásitos puede ser útil de cara a la elaboración de nuevas vacunas y productos terapéuticos. El autor, tras describir las principales herramientas de la genómica funcional, expone los recursos genómicos existentes para el ganado y examina las perspectivas y dificultades que anuncia la genómica funcional con vistas a mejorar la salud y el bienestar del ganado.
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